Latest News On Facebook Live

Latest KFF Health News Stories

Facebook Live: Intimate Lessons From The Front Lines Of Family Caregiving

KFF Health News Original

Family caregivers are the backbone of our nation’s system of long-term care for older adults. Every year, more than 34 million unpaid caregivers — mostly family members — provide essential aid to adults age 50 and older, helping with tasks such as bathing or dressing and, increasingly, performing complex medical tasks such as managing medications, dressing wounds and operating medical equipment.

Facebook Live: The Cancer Divide

KFF Health News Original

Californians and Americans are living longer with cancer — but some are living longer than others. California Healthline’s Facebook Live addresses disparities in cancer diagnosis, treatment and care — and what can be done about them.

KHN Conversation On Overtreatment

KFF Health News Original

Physicians estimate that 21 percent of medical care is unnecessary — a problem that costs the health care system at least $210 billion a year. KHN hosted a forum on how too much medicine can cause harm.

Facebook Live: Vaping Unveiled

KFF Health News Original

Nicotine-loaded e-cig juices that spoof popular treats — marketed to help adults kick the smoking habit— instead may be luring youths into addiction. California Healthline’s Facebook Live peeled back the curtains on this wolf in sheep’s clothing.

KHN Conversation On Living Well With Dementia

KFF Health News Original

Listen and learn from this Kaiser Health News’ Facebook Live event. “Navigating Aging” columnist Judith Graham led a discussion about dementia, one of the most challenging chronic conditions for individuals and their families — which affects millions of American families.

Facebook Live: It’s 2018, Can Big Pharma Hold The Line Against Pricing Controls?

KFF Health News Original

In this chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.